Big Pharma Hikes Prices on Rare Disease Drugs – As Medicare Protections are Weakened

Patients For Affordable Drugs is released a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package. 

Click here to download